Murenje, Vernon
Omollo, Victor
Gonouya, Paidemoyo
Hove, Joseph
Munyaradzi, Tinashe
Marongwe, Phiona
Tshimanga, Mufuta
Chitimbire, Vuyelwa
Xaba, Sinokuthemba
Mandisarisa, John
Balachandra, Shirish
Makunike-Chikwinya, Batsirai
Holec, Marrianne
Mangwiro, Tonderayi
Barnhart, Scott
Feldacker, Caryl
Article History
Received: 31 August 2021
Accepted: 2 February 2022
First Online: 16 February 2022
Declarations
:
: Approval for this routine program monitoring and evaluation using de-identified data were provided by Medical Research Council of Zimbabwe (MRCZ) and the US Centers for Disease Control and Prevention (CDC) Center for Global Health. Specific language in the approval includes quality assurance activities focused on fistulas and other severe, rare adverse events. This care series does not meet the criteria for <i>research</i> according to U.S. Federal Office for Human Research Protections; therefore, this specific activity was not reviewed by the University of Washington Internal Review Board.
: Consent for publication of de-identified data was waived by Medical Research Council of Zimbabwe’s (MRCZ) National Health Research Development Committee and the US Centers for Disease Control and Prevention (CDC) Center for Global Health’s Office of Associate Director for Science.
: The authors declares that they have no competing interests.